KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals, Inc. was founded in 1951 and is based in Kunming, the People's Republic of China.
KPC Pharmaceuticals Dividend Announcement
• KPC Pharmaceuticals announced a annually dividend of ¥0.20 per ordinary share which will be made payable on 2024-07-31. Ex dividend date: 2024-07-31
• KPC Pharmaceuticals annual dividend for 2024 was ¥0.20
• KPC Pharmaceuticals annual dividend for 2023 was ¥0.16
• KPC Pharmaceuticals's trailing twelve-month (TTM) dividend yield is 1.33%
• KPC Pharmaceuticals's payout ratio for the trailing twelve months (TTM) is 70.44%
KPC Pharmaceuticals Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-31 | ¥0.20 | annually | 2024-07-31 |
2023-07-31 | ¥0.16 | annually | 2023-07-31 |
2022-05-30 | ¥0.27 | annually | 2022-05-30 |
2021-06-23 | ¥0.23 | annually | 2021-06-23 |
2020-06-10 | ¥0.20 | annually | 2020-06-10 |
2019-06-18 | ¥0.10 | annually | 2019-06-18 |
2017-05-19 | ¥0.18 | annually | 2017-05-19 |
2016-05-09 | ¥0.41 | annually | |
2015-04-30 | ¥0.17 | annually | |
2014-06-20 | ¥0.35 | annually | |
2013-05-27 | ¥0.30 | annually | |
2012-04-18 | ¥0.20 | annually |
KPC Pharmaceuticals Dividend per year
KPC Pharmaceuticals Dividend growth
KPC Pharmaceuticals Dividend Yield
KPC Pharmaceuticals current trailing twelve-month (TTM) dividend yield is 1.33%. Interested in purchasing KPC Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:
KPC Pharmaceuticals Financial Ratios
KPC Pharmaceuticals Dividend FAQ
Other factors to consider when evaluating KPC Pharmaceuticals as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy KPC Pharmaceuticals stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: KPC Pharmaceuticals's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, KPC Pharmaceuticals publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, KPC Pharmaceuticals distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from KPC Pharmaceuticals are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: KPC Pharmaceuticals sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, KPC Pharmaceuticals distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: KPC Pharmaceuticals declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of KPC Pharmaceuticals's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review KPC Pharmaceuticals's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.